Key Investor Information This document provides you with key investor information about this UCITS (the "Fund"). It is not marketing material. The information is required by law to help you understand the nature and the risks of investing in this Fund. You are advised to read it so you can make an informed decision about whether or not to invest. Amundi IBEX 35 UCITS ETF Acc ISIN code: (C) FR0010655746 This Fund is managed by Amundi Asset Management, an Amundi Group company Objectives and investment policy The Fund is a passively managed index-tracking UCITS. The Fund's management objective is to replicate, both upwards and downwards, the change in the EUR-denominated IBEX 35 Net Return Index (net dividends reinvested) (the "Benchmark Index"), the main Spanish stock market index, while minimising the tracking error between the Fund's performance and that of the Benchmark Index. The tracking error anticipated under normal market conditions is indicated in the Fund’s prospectus. More detailed information on the Bolsa Madrid indices is available on the BolsaMadrid website (https://www.bolsasymercados.es/bme-exchange/en/Indices/Summary). The Fund aims to achieve its objective through direct replication, i.e. by investing primarily in the components of the Benchmark Index. In order to optimise the replication of the Benchmark Index, the Fund may use a sampling technique and guaranteed temporary sales of securities. The possible use of these techniques is indicated at amundietf.com. The current composition of the Fund's portfolio is set out on amundietf.com. Furthermore, the indicative net asset value is published on the Fund’s Reuters and Bloomberg pages and may also appear on its markets’ websites. The Fund is eligible for the French Equity Savings Plan (PEA) and therefore invests a minimum of 75% of its assets in equities of European Union companies. The Fund's net profit as well as its net realised capital gains are automatically reinvested. You may resell your units during the trading hours of the various stock exchanges, provided that the Market Makers can maintain market liquidity. Recommendation: this SICAV may not be appropriate for investors who plan to withdraw their money within 5 years. Risk and reward profile Lower risk, Higher risk,Particular risks for the UCITS not included in this indicator are: Counterparty risk: The Fund is exposed to the risk of insolvency or other potentially lower return potentially higher return types of default of any counterparty with which it enters into an agreement or transaction, particularly in the case of financial derivative instruments 1 2 3 4 5 6 7 traded over the counter or securities delivered under securities financing transactions. Such an event may result in a significant decline in the net This Fund's risk level reflects that of the equities of eurozone countries. asset value of the Fund. In accordance with the regulations applicable to The initial capital invested is not guaranteed. the Fund, this risk may not exceed 10% of the total assets of the Fund for Historical data such as that used to calculate the synthetic indicator may not a given counterparty. be a reliable indicator of the future risk profile of the Fund. The risk category associated with this SICAV is not guaranteed and may change over time. The occurrence of one of these risks may decrease the net asset value of The lowest category does not mean “risk free”. your portfolio. 1/2 Amundi IBEX 35 UCITS ETF Acc Charges The charges and fees paid are used to cover the costs of running the Fund, including the costs of marketing and distributing shares. These charges reduce the potential growth of your investment.*On the secondary market: The Fund is an ETF, so investors who are not Authorised One-off charges taken before or after you investParticipants should in principle buy or Entry charge Not applicable to investors on the sell the Fund’s shares on the secondary market. On the secondary market, investorscan be subject to brokerage feessecondary market* and/or transaction fees related to the placement of their purchase/sale order on therelevant stock exchange. These fees are collected by market Exit chargeNot applicable to investors on theintermediaries and are not levied by/returned to the Fund or the Management Company.secondary market* Investors may also pay an additional amountas a result of the difference between the sale price and the purchase price of the Fund’s The percentage indicated is the maximum that can be deducted from your shares (bid-ask spread). capital before it is invested (entry) or redeemed (exit). On the primary market: Authorised Participants who subscribe/redeem their shareswith the Fund directly will pay the costs applicable Charges levied by the SICAV over a yearto the primary market of the Fund as described in section 4 of the prospectusThe ongoing charges are based on the figures for the current year. This Ongoing charges0.30% of average net assetspercentage may vary from year to year. It excludes: Charges levied by the SICAV in certain circumstances Performance fees,Brokerage fees, except for the entry and exit charges paid by the UCITS Performance fee0when buying or selling units in another Fund. For more information about the charges of this Fund, please refer to the "Costs and Fees" section of the Fund's prospectus, which is available at amundietf.com. Past performance Performance is not constant over time and is no guarantee of future performance. The year-on-year performances presented in this chart are calculated 54.8% 54.2% after deduction of all fees charged by the Fund.60.% The SICAV was formed on 20 September 2018. 50 The reference currency is 40 the euro. 30 The Fund replicates the Benchmark Index and implements an exchange 20 hedging strategy. This strategy follows the exchange hedging 10 methodology of the index provider as accurately as possible. The 00 0 00 0 00 0 Fund's performance is thus compared to that of the exchange-hedged 2021 20222023 2024 2025 index whose methodology is followed by the Fund.Amundi IBEX 35 UCITS ETF Acc Benchmark indexPractical information Name of the Depositary: SOCIETE GENERALE. Name of the market-maker: SOCIETE GENERALE. The latest prospectus and most recent periodic disclosure documents, and all other useful information, are available free of charge from the Management Company. Updated details on the Management Company's remuneration policy are available on its website or free of charge upon written request to it. In particular, this policy describes the calculation methods applied to the remuneration and benefits for certain categories of employees, the entities responsible for their allocation and the composition of the Remuneration Committee. The net asset value of the Fund is available on request from the Management Company and on its website amundietf.com. Information on market-makers, stock markets and trading procedures is available on the Fund’s webpage at amundietf.com. The indicative net asset value is published in real time by the stock exchange operator during trading hours. The UCITS is not available to residents of the United States of America/"U.S. Person”, as defined on the Management Company's website amundietf.com and/or in the prospectus. The transparency policy and information about the asset composition of the Funds is available at amundietf.com. Depending upon your personal tax position, capital gains and any income associated with holding securities in the Fund may be subject to taxation. We advise you to consult your usual advisor. Amundi Asset Management may be held liable solely on the basis of any statement contained in this document that is misleading, inaccurate or inconsistent with the relevant parts of the prospectus for the UCITS. This Fund is approved in France and regulated by the French Market Regulator (AMF). The Management Company, Amundi Asset Management, is authorised in France and regulated by the French market regulator, the Autorité des marchés financiers. This key investor information is accurate as at February the 14th, 2026. Amundi IBEX 35 UCITS ETF Acc 2/2